V-Lab
Apimeds Pharmaceutica US Inc Asymmetric ILLIQ Liquidity Analysis
High-persistence model: shocks decay very slowly, so the theoretical long-run value may not be practically meaningful
Illiquidity prediction for Friday, August 21st, 2026
1 Day
530,070.20
decreased by 128,646.30
1 Week
657,996.72
decreased by 719.78
1 Month
803,283.77
increased by 144,567.27
Analysis last updated: Thursday, August 20, 2026 at 09:53 PM UTC
News Impact Curve
How returns affect tomorrow's illiquidityIlliquidity Forecast
How illiquidity evolves over timeParameter Estimates
May 9, 2025 to Aug 14, 2026Model Insight
Estimated persistence of 1.000 is at or above 1 (non-stationary): illiquidity shocks do not decay and the long-run level is undefined, so long-horizon forecasts should be treated with caution.
μ
ILLIQ-AMEM Model
Tap to view equation
| Parameter | Value | t-statistic |
|---|---|---|
ω const Unconditional variance weight | 5.0000 | 0.00 |
α ARCH Response to squared shocks | 0.1608 | 5.98*** |
β GARCH Volatility persistence | 0.8047 | 78.03*** |
γ leverage Additional response to negative shocks | 0.0691 | 1.55 |
Persistence:
1.000
Half-life:
-
Other Apimeds Pharmaceutica US Inc Analyses
Other Asymmetric ILLIQ Analyses on Equities